Connect your AI

Aspen Aerogels ASPN Payments Of Fees And Issuance Costs From Offering Of Common Stock

Other financials

Income statement

Revenue$37.9M-51.9%

Gross profit$4.3M-81.3%

Operating income-$20.8M+93.0%

Net income-$23.7M+92.1%

EPS (diluted)-$0.29+92.1%

Balance sheet

Cash & equivalents$173.9M-9.5%

Total debt$113.4M-18.8%

Total equity$213.5M-32.2%

Total assets$410.5M-26.0%

Cash flow

Operating cash flow$34.1M+506%

CapEx$1.4M-89.5%

Free cash flow$32.8M+545%

Valuation

Market cap$470.74M-1.1%

Enterprise value$410.28M-3.1%

P/S2×+1.0×

Profitability

Gross margin32.9%-7.1pp

Operating margin-43.3%-8.2pp

Net margin-48.6%-9.9pp

FCF margin-22.3%-10.1pp

Returns & leverage

Return on equity-42.4%-12.2pp

Debt / equity0.5×+0.1×

Current ratio2.9×-1.3×

Where this comes from

Reported directly by Aspen Aerogels in its filing.

Tagged under the XBRL concept aspn:PaymentsOfFeesAndIssuanceCostsFromOfferingOfCommonStock.

The official record: Aspen Aerogels’s 10-Q, filed August 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Aspen Aerogels's payments of fees and issuance costs from offering of common stock.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Aspen Aerogels's payments of fees and issuance costs from offering of common stock?: Aspen Aerogels (ASPN) reported payments of fees and issuance costs from offering of common stock of $10K in Q2 2025.